LR - the bottomline result based story may not be as speculative
Consider the timing - all on board were/are expecting some kind of deal with big pharma - Leo declared ph 3 study in 2015 with single dose - but looking at early bottomline results - he is not sure about deal - so he concludes that he has to go alone and needs money - he files shelf
People in know - start getting these details and the buying support is reduce and price start dropping
Todays price action will tell the story unless there is a PR